Results 131 to 140 of about 5,674 (178)

Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. [PDF]

J Viral Hepat
Luong CL, Ellett LK, Pratt N, Staff K, Janetzki J.   +4 more
europepmc   +1 more source

A novel model of care; Telemedicine and peer support for HCV care among HIV-infected people who inject drugs in remote Myanmar: a retrospective study. [PDF]

Harm Reduct J
Tun NN, Smithuis F, Tun NL, Hteik MMM, Lynen L, Conlon CP, Gils T, van Olmen J, Decroo T.   +8 more
europepmc   +1 more source

Enhanced information cross-attention fusion for drug-target binding affinity prediction. [PDF]

PeerJ Comput Sci
Fei A, Wang Y, Ruan T, Zhang Y, Yao M, Wang L.   +5 more
europepmc   +1 more source

Efficacy of Sofosbuvir-Velpatasvir-Ribavirin Regimen for Retreatment of Chronic Hepatitis C in Patients With Prior DAA Failure: A Retrospective Study From a National Treatment Center. [PDF]

Int J Hepatol
Singh S, Sengupta S, Kumar D, Mukherjee K, Hasan AMD, Sadhukhan P, Ahammed SM.   +6 more
europepmc   +1 more source

Decentralised Hepatitis C Management: A Simplified, Integrated Model of Care in a Primary Health Centre in Pakistan, August 2022-June 2023. [PDF]

J Viral Hepat
Mazzilli S, Aslam MK, Ahmed M, Wailly Y, Miazek M, Ashraf S, Ravji A, de Glanville WA, Isaakidis P.   +8 more
europepmc   +1 more source

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice. [PDF]

Viruses
Mattos M, Sacramento CQ, Ferreira AC, Fintelman-Rodrigues N, Pereira-Dutra FS, de Freitas CS, Gesto JSM, Temerozo JR, Silva APDD, Moreira MTG, Silva RSC, Silveira GPE, Pinto DP, Pereira HM, Fonseca LB, Alves Ferreira M, Blanco C, Viola JPB, Bou-Habib DC, Bozza PT, Souza TML.   +20 more
europepmc   +1 more source

Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. [PDF]

BMJ Open Gastroenterol
Mustafa A, Davlidova S, Abidi SH, Begimbetova D, Heimer R, Vermund SH, Ali S.   +6 more
europepmc   +1 more source

Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. [PDF]

Viruses
AlKaabi H, AlSinani S, El-Kassas M, Alswat KA, AlNaamani KM.   +4 more
europepmc   +1 more source

Epidemiological and clinical profile of viral hepatitis B and C among adult patients attending Hepatitis clinic at Rwanda Military Referral and Teaching Hospital: a retrospective cross-sectional study. [PDF]

BMC Infect Dis
Shema D, Nelson NM, Nsanzimfura D, Mfashingabo F, Seruyange E.   +4 more
europepmc   +1 more source

Cardiac safety of sofosbuvir-based direct-acting antivirals in hepatitis C patients with pre-existing heart disease. [PDF]

Clinics (Sao Paulo)
Hanafy AS, Mohamed MS, Attia O, Mohammed AFE, Hassaneen AM, Naguib R, Fahmy EK, Elkattawy HA.   +7 more
europepmc   +1 more source